2. UroToday Home
  3. Video Lectures

ASCO 2020 Videos

Cabozantinib in Combination with Atezolizumab in Metastatic Castration-Resistant Prostate Cancer: COSMIC-021 - Neeraj Agarwal
January 29, 2021
Details
Personalized Approaches to the Treatment of Prostate Cancer - Kenneth Pienta and James Gulley
July 10, 2020
Details
Final Overall Survival Analysis of the PROSPER Trial in Nonmetastatic Castration-Resistant Prostate Cancer - Karim Fizazi
July 3, 2020
Details
PROSPER Trial: Significant Improvement in Metastasis-Free Survival (MFS) and Overall Survival (OS) Demonstrated Nonmetastatic Castration-Resistant Prostate Cancer Patients - Fred Saad
July 3, 2020
Details
Blue Light Cystoscopy with Cysview®: Tips and Tricks - Anne Schuckman
June 30, 2020
Details
ARAMIS Trial Demonstrates Significant Improvement in Overall Survival in nmCRPC - Neal Shore
June 29, 2020
Details
Advancements in Treatments for Metastatic Urothelial Carcinoma (mUC) - Petros Grivas
June 29, 2020
Details
JAVELIN Bladder 100: Results of First-line Maintenance Therapy Plus Best Supportive Care Demonstrates Significant Prolonged OS in Advanced Urothelial Cancer - Cora Sternberg
June 28, 2020
Details
AUA Guidelines Case-Based Panel Discussion: Bladder Cancer (Non-muscle and Muscle Invasive) - Joshua Meeks and Sima Porten
June 26, 2020
Details
Changing the Mechanism of Action in The Treatment of Metastatic Castration Resistant Prostate Cancer (mCRPC) - Phillip Koo
June 24, 2020
Details
Cabazitaxel Demonstrates Improved Overall Survival when Compared to an Alternative AR-targeted Agent (CARD) - Cora Sternberg
June 21, 2020
Details
Advanced Renal Cell Carcinoma Clinical Research Outcomes and Clinical Implications from ASCO 2020 - Toni Choueiri
June 14, 2020
Details
Assessing the Potential Cost-Effectiveness of the Addition of Atezolizumab to First-Line Platinum Chemotherapy in Advanced Urothelial Carcinoma - Ali Khaki
June 11, 2020
Details
Overall Survival Results of Phase III ARAMIS Study of Darolutamide Added to ADT for Non-metastatic Castration-Resistant Prostate Cancer (nmCRPC) - Karim Fizazi
June 9, 2020
Details
The Role of Neoadjuvant Therapy for Patients with Localized Prostate Cancer - Rana R. McKay
June 8, 2020
Details
HERO Phase III Trial: Results Comparing Relugolix, an Oral GnRH Receptor Antagonist Vs. Leuprolide Acetate for Advanced Prostate Cancer - Neal Shore
June 7, 2020
Details
IMvigor010 Primary Analysis from a Phase III Randomized Study of Adjuvant Atezolizumab versus Observation in High-Risk Muscle-Invasive Urothelial Carcinoma - Thomas Powles & Matthew Galsky
May 31, 2020
Details
JAVELIN Bladder 100: Avelumab for Previously Untreated Locally Advanced or Metastatic Urothelial Carcinoma - Thomas Powles
May 31, 2020
Details
Immunogenomic Characterization of Advanced Clear Cell Renal Cell Carcinoma Treated with PD-1 Blockade - David Braun
May 30, 2020
Details
The Delivering of Genetic Counseling, Processes and Outcomes, The ProGen Study - Mary-Ellen Taplin
May 30, 2020
Details
OMNIVORE: Optimized Management of Nivolumab and Ipilimumab in Advanced Renal Cell Carcinoma - Rana McKay
May 30, 2020
Details
KEYNOTE-426: Pembrolizumab plus Axitinib versus Sunitinib as First-Line Therapy for Advanced Renal Cell Carcinoma (RCC) - Brian Rini
May 28, 2020
Details
ARAMIS Trial: Darolutamide Demonstrates Improved Overall Survival in Nonmetastatic Castration-Resistant Prostate Cancer (nmCRPC) - Fred Saad
May 28, 2020
Details
CONDOR: Study of 18F-DCFPyL PET/CT Imaging in Patients with Suspected Recurrence of Prostate Cancer - Michael J. Morris
May 28, 2020
Details
68Ga-PSMA PET: A Novel Imaging Technique Prior to Radical Prostatectomy in Men with Intermediate or High Risk Prostate Cancer - Thomas Hope
May 28, 2020
Details